Counting Cases and Deaths by Age Tells Us About COVID-19 Infectious and Lethal Components
Michaelson, J. S.
Show abstract
Gauging COVID-19s lethality, and how vaccination can reduce that lethality, has been challenging. Here, a new method, Gompertzian Analysis, counting cases and deaths, by age, and displaying them on logarithmic graphs, is outlined, and its first findings presented: FIRST, COVID-19 Gompertzian Lethality (Deaths/Cases) exhibits an ~10,000-fold exponential increase in the chance of death with age, the Gompertzian Force of Mortality, captured by the Gompertz Mortality Equation. SECOND, COVID-19 Pasteurian Infectivity (Cases/Population) occurs at similar rates across ages. THIRD, the same Gompertzian Force of Mortality characterizes other diseases and all-cause mortality, possibly from loss of Mitotic Dilution of toxic compounds due to decline in mitosis. FOURTH, resistance to COVID-19 infectivity and lethality appear to be separate processes. FIFTH, Over the past several years, Gompertzian Lethality, has declined, but not Pasteurian Infectivity. SIXTH, with each variant, Gompertzian Lethality has declined, but not Pasteurian Infectivity. SEVENTH, the unvaccinated have seen a decline in Gompertzian Lethality, less than the vaccinated, ascribable to infection, at the cost of lives lost. EIGHTH, different vaccines have different reductions in Gompertzian Lethality and Pasteurian Infectivity. NINTH, vaccination has reduced Pasteurian Infectivity, but not enough to suppress the pandemic. TENTH, vaccination has reduced Gompertzian Lethality, with sequential vaccination pointing linearly towards zero death after 3 or 4 boosters, without signs of waning. CONCLUSION: Gompertzian Analysis provides new, practical, actionable, information for understanding, and minimizing, the lethal burden of COVID-19 and other diseases.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The Mean Unfulfilled Lifespan (MUL): A new indicator of the impact of mortality shocks on the individual lifespan, with application to global 2020 quarterly mortality from COVID-19 94%
- Beyond the new normal: assessing the feasibility of vaccine-based elimination of SARS-CoV-2 93%
- Understanding the immunological landscape of England during SARS-CoV2 Omicron variant wave 93%
Similar papers in this journal
- Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials 92%
- Years of Life Lost in the United States During the COVID-19 Pandemic, March 2020 to October 2021 91%
- Assessing COVID prevention strategies to permit the safe opening of college campuses in fall 2021 90%
Similar papers in this journal
- COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact 93%
- Statistics of antibody binding to the spike protein explain the dependence of COVID 19 infection risk on antibody concentration and affinity 92%
- Importance of epidemic severity and vaccine mode of action and availability for delaying the second vaccine dose 92%
Similar papers in this journal
- Is mandatory vaccination in population over 60 adequate to control the COVID-19 pandemic in E.U.? 93%
- Epidemiological differences in the impact of COVID-19 vaccination in the United States and China 92%
- Vaccination is reasonably effective in limiting the spread of COVID-19 infections, hospitalizations and deaths with COVID-19 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.